Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
Gompel
A
A
Frances
C
C
Piette
J C
JC
Blanc
A S
AS
Cordoliani
F
F
Piette
A M
AM
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008177:Lupus Vulgaris / Q000188:drug therapy*; D010053:Ovary / Q000187:drug effects / Q000503:physiopathology; D013281:Stomatitis, Aphthous / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D013792:Thalidomide